SCM
CPIX icon

Stonepine Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Stonepine Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-188,703
Closed -$557K – 30
2020
Q4 		$557K Sell
188,703
-400,794
-68% -$1.21M 0.43% 21
2020
Q3 		$1.89M Sell
589,497
-87,095
-13% -$286K 1.97% 13
2020
Q2 		$2.25M Sell
676,592
-231,143
-25% -$840K 4.36% 9
2020
Q1 		$3.29M Buy
907,735
+11,565
+1% +$51.8K 3.48% 14
2019
Q4 		$4.62M Buy
896,170
+35,721
+4% +$189K 3.22% 12
2019
Q3 		$5.1M Sell
860,449
-11,313
-1% -$62.9K 4.95% 6
2019
Q2 		$5.55M Sell
871,762
-330,213
-27% -$2M 3.82% 9
2019
Q1 		$6.98M Sell
1,201,975
-111,454
-8% -$646K 4.02% 9
2018
Q4 		$7.92M Buy
1,313,429
+95,028
+8% +$569K 6.96% 4
2018
Q3 		$6.96M Buy
1,218,401
+15,062
+1% +$88.7K 4.07% 9
2018
Q2 		$7.38M Sell
1,203,339
-119,702
-9% -$749K 4.48% 7
2018
Q1 		$8.84M Buy
1,323,041
+16,130
+1% +$111K 4.74% 7
2017
Q4 		$9.62M Buy
1,306,911
+34,720
+3% +$255K 5.77% 8
2017
Q3 		$8.98M Buy
1,272,191
+163,024
+15% +$1.13M 5.29% 11
2017
Q2 		$7.76M Buy
1,109,167
+369,250
+50% +$2.44M 4.19% 10
2017
Q1 		$5.13M Buy
739,917
+120,379
+19% +$730K 2.89% 14
2016
Q4 		$3.41M Buy
619,538
+295,791
+91% +$1.54M 2.03% 15
2016
Q3 		$1.62M Buy
323,747
+194,949
+151% +$917K 1.32% 12
2016
Q2 		$580K Buy
+128,798
New +$590K 0.59% 21

Other funds holding CPIX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.55B AUM 31.3% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Stonepine Capital Management's CPIX Position: Q1 2021 in Review

Stonepine Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2021, closing a stake of 188,703 shares — an estimated $557K sold.

Stonepine Capital Management first reported a position in CPIX in Q2 2016 and held it in 19 quarters. The position peaked at $9.62M in Q4 2017. 31 funds tracked by Wall St. Rank hold CPIX as of Q1 2021.

  • Stonepine Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Stonepine Capital Management sold 188,703 Cumberland Pharmaceuticals shares in Q1 2021, an estimated $557K.
  • Stonepine Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2016 and held it in 19 quarters.
  • Stonepine Capital Management's Cumberland Pharmaceuticals position peaked at $9.62M in Q4 2017.
  • 31 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2021.

Based on Stonepine Capital Management's 13F filing for Q1 2021, filed 14 May 2021.